Blue Star
Blue Star
Consumer Goods F&OKey Fundamentals
SmallcapHousehold AppliancesConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has delivered good profit growth of 49.6% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 33.0%
Weaknesses
1- Stock is trading at 9.34 times its book value
Growth Rate
AI Analysis — Bull vs Bear
Blue Star Ltd commands a market cap of ₹31,110 Cr at a PE of 61.1x and PB of 9.07x, reflecting premium valuation. The company has delivered strong 5-year profit CAGR of ~50% and 5-year sales CAGR of 24%, though TTM sales growth has moderated to 6% and TTM profit growth has turned slightly negative at -1%.
- Exceptional 5-year compounded profit growth of 50% CAGR, significantly outpacing broader market earnings growth
- Robust 5-year sales CAGR of 24%, indicating sustained top-line momentum over a meaningful period
- Consistent ROE averaging 19-20% over 3, 5, and 10-year periods, reflecting efficient capital allocation
- Healthy dividend payout ratio of 33.0%, demonstrating shareholder return discipline with a current yield of 0.56%
- Strong long-term stock price CAGR of 29% over 5 years and 20% over 10 years, reflecting sustained wealth creation
- 10-year compounded sales growth of 13% and profit growth of 18% show the company has compounded steadily across multiple business cycles
- 3-year profit CAGR of 26% and sales CAGR of 16% indicate the recent growth acceleration is not a one-off event
- PE ratio of 61.1x is significantly elevated, leaving limited margin of safety if earnings growth disappoints
- PB ratio of 9.07x is very high, meaning the stock prices in substantial future growth already
- TTM profit growth has turned negative at -1%, signalling a potential earnings deceleration after years of strong growth
- TTM sales growth has slowed sharply to 6% compared to the 5-year CAGR of 24%, raising concerns about demand softening
- Stock price has declined 20% over the past 1 year, indicating the market is already repricing growth expectations lower
- Last year ROE of 17% has dipped below the 3-year average of 19% and 5-year average of 20%, suggesting returns on equity may be under pressure
- At current valuations, even modest earnings misses could trigger sharp price corrections given the premium multiple
- Dividend yield of just 0.56% offers minimal income cushion during periods of capital depreciation
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- EBITDA drops 12%, margins compress Aug 18
Q1 EBITDA fell 12% to ₹175 crore vs Street estimate of ₹247 crore, with margin contracting to 5.2% from 6.7% YoY. Revenue of ₹3,378 crore also missed the poll estimate of ₹3,547 crore.
- Weak monsoon drags cooling demand Aug 20
Blue Star flagged below-normal monsoon conditions as a key headwind for cooling products, potentially compressing the selling season and moderating volume offtake.
- Stock down 23% YTD, underperforms Voltas Aug 18
Blue Star shares have corrected 23% YTD versus 8% for Voltas, reflecting ongoing market concerns about margin pressures and competitive positioning. Stock was trading 0.3% lower at ₹1,503.2 on Aug 18.
- HSBC upgrades to buy, ₹1,780 target Aug 18
HSBC upgraded Blue Star from hold to buy with a ₹1,780 price target implying 18% upside, citing strong order book, data centre play, and scope for margin expansion.
- RAC industry grew 25% in Q1 Aug 18
The room AC industry grew 25% in the June quarter with volume growth of 20-22%, providing a strong sectoral tailwind for Blue Star's core cooling business.
- MedTech divestiture completed for ₹40 crore Sep 5
Blue Star completed the slump sale of its MedTech business to Cyrix Healthcare for up to ₹40 crore, effective Sep 1, 2026. The division contributed just 0.33% of consolidated operations, sharpening focus on core business.
- Analyst consensus remains mixed Aug 18
Of 27 analysts covering Blue Star, 13 have a buy rating, 9 hold, and 5 sell, reflecting divided views on the stock's near-term outlook despite the HSBC upgrade.
TL;DR: Blue Star is navigating a tough patch with Q1 margins compressing sharply to 5.2% and the stock down 23% YTD, though the underlying RAC industry remains strong at 25% growth. The HSBC upgrade to buy with an ₹1,780 target and the MedTech divestiture signal confidence in the core business focus and data centre opportunity. Key risks remain weak monsoon impact on cooling demand and competitive pressure from Voltas. The trend is cautiously improving on valuation grounds, but margin recovery in coming quarters will be the critical signal to watch.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,226 | 1,890 | 2,241 | 3,328 | 2,865 | 2,276 | 2,807 | 4,019 | 2,982 | 2,422 | 2,925 | 4,072 | 3,378 |
| Expenses | 2,081 | 1,768 | 2,086 | 3,086 | 2,628 | 2,127 | 2,599 | 3,740 | 2,784 | 2,240 | 2,705 | 3,746 | 3,203 |
| Operating Profit | 145 | 123 | 155 | 242 | 238 | 149 | 209 | 279 | 199 | 182 | 220 | 326 | 175 |
| OPM % | 7% | 6% | 7% | 7% | 8% | 7% | 7% | 7% | 7% | 8% | 8% | 8% | 5% |
| Other Income | 9 | 13 | 13 | 13 | 24 | 19 | 21 | 24 | 16 | 10 | -44 | 45 | 30 |
| Interest | 18 | 18 | 10 | 12 | 8 | 6 | 16 | 19 | 10 | 17 | 22 | 23 | 13 |
| Depreciation | 23 | 23 | 23 | 28 | 28 | 30 | 35 | 35 | 41 | 43 | 46 | 48 | 57 |
| PBT | 114 | 95 | 134 | 214 | 226 | 131 | 179 | 249 | 163 | 132 | 108 | 300 | 135 |
| Tax % | 27% | 26% | 25% | 25% | 25% | 27% | 26% | 22% | 26% | 25% | 25% | 24% | 24% |
| Net Profit | 83 | 71 | 100 | 160 | 169 | 96 | 132 | 194 | 121 | 99 | 81 | 227 | 103 |
| EPS in Rs | 4.33 | 3.44 | 4.88 | 7.81 | 8.21 | 4.68 | 6.45 | 9.42 | 5.88 | 4.82 | 3.92 | 11.04 | 4.99 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,182 | 3,798 | 4,385 | 4,639 | 5,235 | 5,360 | 4,264 | 6,064 | 7,977 | 9,685 | 11,968 | 12,402 | 12,798 |
| Expenses | 3,014 | 3,631 | 4,162 | 4,372 | 4,887 | 5,077 | 4,024 | 5,717 | 7,478 | 9,017 | 11,089 | 11,469 | 11,894 |
| Operating Profit | 168 | 167 | 223 | 266 | 348 | 283 | 240 | 347 | 500 | 669 | 879 | 933 | 903 |
| OPM % | 5% | 4.4% | 5% | 6% | 7% | 5% | 6% | 6% | 6% | 7% | 7% | 8% | 7% |
| Other Income | -34 | 66 | 34 | 22 | 26 | 40 | 62 | 36 | 195 | 44 | 83 | 21 | 41 |
| Interest | 49 | 43 | 38 | 29 | 48 | 29 | 65 | 46 | 55 | 58 | 49 | 72 | 76 |
| Depreciation | 43 | 57 | 61 | 64 | 75 | 88 | 92 | 86 | 85 | 98 | 128 | 179 | 194 |
| PBT | 43 | 132 | 159 | 196 | 251 | 206 | 145 | 251 | 555 | 557 | 785 | 703 | 674 |
| Tax % | -18% | 21% | 23% | 25% | 17% | 32% | 32% | 33% | 28% | 26% | 25% | 25% | — |
| Net Profit | 54 | 106 | 123 | 144 | 190 | 144 | 101 | 168 | 401 | 414 | 591 | 527 | 509 |
| EPS in Rs | 3.01 | 5.82 | 6.44 | 7.5 | 9.87 | 7.44 | 5.21 | 8.71 | 20.79 | 20.18 | 28.75 | 25.66 | 24.77 |
| Div. Payout % | 83% | 56% | 58% | 67% | 51% | 67% | 38% | 57% | 29% | 35% | 31% | 33% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 41 | 41 | 41 |
| Reserves | 438 | 612 | 738 | 774 | 854 | 763 | 866 | 998 | 1,311 | 2,569 | 3,024 | 3,390 |
| Borrowings | 398 | 365 | 221 | 376 | 348 | 520 | 510 | 554 | 662 | 243 | 381 | 810 |
| Other Liabilities | 1,322 | 1,530 | 1,672 | 2,068 | 2,130 | 2,137 | 2,154 | 2,741 | 3,455 | 3,758 | 4,803 | 4,325 |
| Total Liabilities | 2,175 | 2,525 | 2,650 | 3,236 | 3,351 | 3,439 | 3,549 | 4,313 | 5,447 | 6,611 | 8,249 | 8,567 |
| Fixed Assets | 257 | 259 | 356 | 392 | 400 | 444 | 384 | 433 | 859 | 1,165 | 1,536 | 1,697 |
| CWIP | 22 | 16 | 34 | 25 | 41 | 67 | 72 | 152 | 83 | 127 | 123 | 137 |
| Investments | 36 | 242 | 11 | 13 | 15 | 17 | 295 | 162 | 148 | 267 | 432 | 457 |
| Other Assets | 1,860 | 2,007 | 2,250 | 2,806 | 2,895 | 2,911 | 2,799 | 3,565 | 4,357 | 5,053 | 6,158 | 6,276 |
| Total Assets | 2,175 | 2,525 | 2,650 | 3,236 | 3,351 | 3,439 | 3,549 | 4,313 | 5,447 | 6,611 | 8,249 | 8,567 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 215 | 257 | 159 | 19 | 258 | 457 | 350 | 87 | 243 | 289 | 688 | 154 |
| Investing | -49 | -48 | 69 | -88 | -65 | -88 | -238 | -67 | -178 | -524 | -463 | -354 |
| Financing | -190 | -195 | -203 | 51 | -181 | -167 | -70 | -82 | -76 | 365 | -162 | 137 |
| Net Cash Flow | -24 | 13 | 25 | -18 | 13 | 202 | 42 | -62 | -11 | 130 | 63 | -63 |
| Free Cash Flow | 180 | 208 | 52 | -73 | 180 | 376 | 367 | -131 | 26 | -144 | 319 | -169 |
| CFO/OP | 143 | 173 | 70 | 24 | 84 | 192 | 150 | 36 | 67 | 64 | 99 | 35 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 76 | 78 | 75 | 78 | 57 | 69 | 72 | 71 | 74 | 60 | 63 |
| Inventory Days | 79 | 104 | 97 | 152 | 119 | 116 | 143 | 125 | 127 | 106 | 131 | 131 |
| Days Payable | 146 | 211 | 191 | 228 | 211 | 211 | 260 | 223 | 223 | 198 | 209 | 177 |
| Cash Conversion Cycle | 15 | -31 | -16 | -2 | -14 | -38 | -48 | -26 | -25 | -18 | -18 | 16 |
| Working Capital Days | -12 | -17 | 6 | 8 | 8 | -13 | -1 | 6 | 2 | 20 | 16 | 20 |
| ROCE % | 15% | 20% | 20% | 20% | 25% | 19% | 13% | 20% | 25% | 26% | 26% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Blue Star insights
63 extracted metrics + investor summaries across FY11–FY27.
Documents
Frequently Asked Questions about Blue Star
What does Blue Star Ltd do?
Where is Blue Star Ltd (BLUESTARCO) listed?
Which sector does Blue Star Ltd belong to?
What is the market capitalisation of Blue Star Ltd?
What is the PE ratio of Blue Star Ltd?
What is the 52-week high and low of Blue Star Ltd?
Does Blue Star Ltd pay dividends?
What is the Return on Equity (ROE) of Blue Star Ltd?
Company Information
Blue star manufacturers air purifiers, air coolers, water purifiers, cold storage and speciality products. The Company offers turnkey solutions in MEP (Mechanical, Electrical, Plumbing, and Fire-fighting) Projects. It is the largest after-sales service provider for air conditioning and commercial refrigeration products in the country. [1] [2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BLUESTARCO.md for Blue Star Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.